Molecule might be a key player in bridging the valley of death.
In this presentation given at Ending Age-Related Diseases 2020, Dr. Tyler Golato talked about his company, Molecule, highlighting the current problems with pharmaceutical development and offering a new, decentralized method of developing therapies. He discussed the well-known valley of death, the gap between the basic research of academia and the later-stage development of pharmaceutical companies. Dr. Golato advertises Molecule as a method of fostering collaboration between early developers and pharmaceutical companies in order to bridge this gap, particularly in the context of rejuvenation biotechnology.
| HELP SPREAD THE WORD |
| Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension: |
|
|
| Thank You! |
Write a comment: